Renee P. Tannenbaum net worth and biography

Renee Tannenbaum Biography and Net Worth

Director of ANI Pharmaceuticals

Dr. Tannenbaum joined the Board in March 2022. Dr. Tannenbaum currently serves as Head of Corporate Development for Bench International, an executive search firm focused on biotech and life sciences. She also serves as a strategic advisor for several biopharmaceutical and device companies and serves on the Cardiff Oncology, Inc. Board of Directors and as a Board Advisor to Aerami Therapeutics, Inc. She was previously Vice President of Global Partnering at Halozyme, Inc. and Head of Global Customer Excellence at AbbVie, where she was responsible for building commercial capabilities for the organization. Previously, Dr. Tannenbaum served as President of Myrtle Potter & Company, LLC, a global life sciences consulting and advisory firm and Executive Vice President and Chief Commercial Officer at Elan Pharmaceuticals, Inc. Prior to her role at Elan, Dr. Tannenbaum was at Novartis Pharma AG, where she led the Global Commercial Operations organization. She also spent nine years at Bristol-Myers Squibb and 16 years at Merck and Company, Inc. where she held a variety of leadership positions. Dr. Tannenbaum received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Sciences, her M.B.A. from Temple University, and her B.S in Pharmacy from the University of Connecticut.

What is Renee P. Tannenbaum's net worth?: The estimated net worth of Renee P. Tannenbaum is at least $1.26 million as of May 16th, 2024. Dr. Tannenbaum owns 18,211 shares of ANI Pharmaceuticals stock worth more than $1,263,115 as of April 2nd. This net worth estimate does not reflect any other assets that Dr. Tannenbaum may own. Learn More about Renee P. Tannenbaum's net worth.
How do I contact Renee P. Tannenbaum?: The corporate mailing address for Dr. Tannenbaum and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on Renee P. Tannenbaum's contact information.
Has Renee P. Tannenbaum been buying or selling shares of ANI Pharmaceuticals?: Renee P. Tannenbaum has not been actively trading shares of ANI Pharmaceuticals over the course of the past ninety days. Most recently, Renee P. Tannenbaum sold 2,000 shares of the business's stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $63.87, for a transaction totalling $127,740.00. Following the completion of the sale, the director now directly owns 18,211 shares of the company's stock, valued at $1,163,136.57. Learn More on Renee P. Tannenbaum's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 32 times. They sold a total of 248,126 shares worth more than $15,601,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 3/13/2025.

Renee P. Tannenbaum Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/16/2024	Sell	2,000	$63.87	$127,740.00	18,211

Renee P. Tannenbaum Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $69.36

$66.63

$69.45

50 Day Range

MA: $61.08

$54.51

$69.36

2 Week Range

Now: $69.36

$52.50

$70.00

Volume

279,136 shs

Average Volume

256,612 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63